Q2 FY27 Results: Revenue up 22.5% YoY, Interim Dividend of Rs 0.15 Declared

Revenue Growth 20pctPat Growth 25pctExceptional ItemResults View source PDF Explain this filing

SAGILITY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.7%Reaction day

₹45.39

prior close

₹46.65

announcement price

After-mkt

timing

Nifty Smallcap 250market-2.8%+0.1% vs market

IT Enabled Services peers, median of 81sector-2.7%+0.1% vs sector

On the reaction day the stock moved 0.1 pts more than Nifty Smallcap 250 and 0.1 pts more than its IT Enabled Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-1.3

15m

-1.5

30m

-0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.7-2.8+0.1-2.7+0.1

Next day

-1.6-1.7+0.1-2.7+1.0

+1.5+0.5+1.0-1.3+2.7

-0.2+0.8-1.0-0.7+0.5

-1.6+1.5-3.1-1.0-0.6

-7.3pendingpending-2.1-5.2

—————

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · IT Enabled Services peers, median of 81Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sagility Limited's Board approved Q2 FY27 results. Consolidated revenue rose to Rs. 20,320.97 million (up 22.5% YoY), with H1 revenue at Rs. 39,955.80 million (up 25%). PAT for Q2 was Rs. 2,842.12 million and H1 PAT was Rs. 5,010.23 million (up 25.5%). Board declared interim dividend of Rs. 0.15 per share. CareSeed acquired in June; Chirok Health deal announced on October 21.

Likely market impact

Strong revenue and earnings growth. Interim dividend of Rs. 0.15 per share. Acquisitions expand US healthcare footprint.